(STUDY) Popular semaglutide weight loss drugs may be linked to optic neuropathy causing blindness
The following is from MedPage Today. Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective study suggested. Over a mean follow-up of […]
